Generate Biomedicines, Inc. (GENB) vs Ocular Therapeutix, Inc. (OCUL)
- Generate Biomedicines, Inc. GENB 9.83 −6.29%
- Ocular Therapeutix, Inc. OCUL 6.01 0.00%
Generate Biomedicines, Inc. and Ocular Therapeutix, Inc. are both Biotechnology companies. Generate Biomedicines, Inc. and Ocular Therapeutix, Inc. are of similar size ($1.3B and $1.3B). Ocular Therapeutix, Inc. has the higher net margin (−648.6% vs −1,381.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Ocular Therapeutix, Inc. leads on 9 and Generate Biomedicines, Inc. on 6.
Valuation
Profitability
| Metric | GENB | OCUL | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 87.32% | 70.18% |
| Operating margin | (1,382.04%) | (680.91%) | 0.00% |
| Net margin | (1,381.76%) | (648.64%) | 0.00% |
| Free cash flow margin | (1,199.36%) | (530.00%) | 0.00% |
| Return on equity | 1,091.11% | (93.48%) | (50.72%) |
| Return on assets | (56.30%) | (64.30%) | (45.56%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack